Navigation Links
Discovery Institute Bioethicist Lauds Breakthrough in Stem Cells Research that Eliminates Need for Human Cloning
Date:11/20/2007

SEATTLE, Nov. 20 /PRNewswire-USNewswire/ -- Scientists have announced that they successfully reprogrammed adult cells back to an embryonic-like state, opening the possibility of patient-specific medical treatments and research without the need to clone human life.

Wesley J. Smith, the Discovery Institute's Senior Fellow in Bioethics and author of Consumer's Guide to a Brave New World, hailed the breakthrough as demonstrating that ethical science is also good science: "Everyone should applaud this tremendous scientific achievement. We now have the very real potential of developing thriving and robust stem cell medicine and scientific research sectors that will bridge, rather than exacerbate, our moral differences over the importance and meaning of human life."

"This breakthrough demonstrates the creativity and intelligence of the science sector," Smith added. "I think President Bush deserves some credit for the exciting research into 'alternative methods' of deriving pluripotent cells. Had the president followed the crowd instead of leading it, most research efforts would have been devoted to trying to perfect embryonic stem cell and human cloning research-which despite copious funding have not worked out yet as scientists originally had hoped."

Smith called upon the NIH, state, and private research funders to shift their focus away from human cloning research and into the more viable alternatives.

"We should now move to outlaw all human cloning," Smith explained. "It is not only unethical to treat human life like an item of manufacture, but it will divert billions of dollars and many years of our best researchers' efforts way from areas of advancement that have the chance to do tremendous good without the terrible moral cost of permitting human cloning."


'/>"/>
SOURCE Discovery Institute
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
2. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
3. European Centre for Modern Drug Discovery Established in Hamburg
4. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
5. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
6. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development
7. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
8. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
9. Tandem Labs New England Facility Doubles Discovery Support Capacity - Increasing Foothold in New England
10. New method of selecting DNA for resequencing accelerates discovery of subtle DNA variations
11. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Soligenix, Inc. (OTCQB: ... company focused on developing and commercializing products to ... medical need, announced today the long-term follow-up data ... (dusquetide), a first-in-class Innate Defense Regulator (IDR), in ... and neck cancer patients undergoing chemoradiation therapy (CRT).  ...
(Date:12/8/2016)... , Dec. 8, 2016 Savannah River ... technologies and selected NewTechBio,s NT-MAX Lake & ... based beneficial bacteria, in conjunction with Hexa Armor/ ... deficiencies with National Pollutant Discharge Elimination System requirements. ... experienced a steady history of elevated pH levels, ...
(Date:12/8/2016)... Dec. 8, 2016   Biocept, Inc . ... provider of clinically actionable liquid biopsy tests to ... clinical data featuring its Target Selectorâ„¢ Circulating Tumor ... for the detection of actionable biomarkers in patients ... sponsored by Sara Cannon Research Institute (SCRI), the ...
(Date:12/7/2016)... ... 2016 , ... Huffman Engineering, Inc. , a leader ... System Integrator Partner. Huffman Engineering is the only Nebraska-based company recognized as ... Partner certification gives customers confidence that our engineers are fully trained and can ...
Breaking Biology Technology:
(Date:11/29/2016)... Nov. 29, 2016   Neurotechnology , ... object recognition technologies, today released FingerCell 3.0, ... recognition solutions that run on low-power, low-memory ... using less than 128KB of memory, enabling ... that have limited on-board resources, such as: ...
(Date:11/24/2016)... 2016 Cercacor today introduced Ember TM ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, ... Rate in approximately 30 seconds. Smaller than a smartphone, ... access to key data about their bodies to help ... Hemoglobin carries oxygen to muscles. When ...
(Date:11/21/2016)... 21, 2016   Neurotechnology , a provider ... today announced that the MegaMatcher On Card fingerprint ... for the NIST Minutiae Interoperability Exchange (MINEX) ... mandatory steps of the evaluation protocol. ... test of fingerprint templates used to establish compliance ...
Breaking Biology News(10 mins):